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Whether or not treatment ofcancer of the breast materially alters the survival
rate is a problem which has given rise in recent years to much speculation and
several papers in the medical literature. The evidence for treatment has been
indirect, being based upon comparisons with groups of untreated patients not
directly comparable with the treated groups. From a statistical point of view
the best method of attacking the problem would be to treat alternate patients
but for numerous reasons this is impossible. Another method, statistically
acceptable, is tomatcheach untreatedpatientwith atreated one. Such a matching
technique has been employed in the present paper.
This study includes 230 cases of untreated cancer of the breast which were
collected from cancer treatment centres in Canada, England, France and the
United States. For each case the following data were requested
(a) age at diagnosis
(b) duration of symptoms before diagnosis
(c) pathological diagnosis
(d) clinical findings
(1) confined to breast (operable)
(2) confined to breast and axilla (operable)
(3) confined to breast or breast and axilla but inoperable because of
fixation to chest wall or fixation ofaxillary lymph nodes
(4) evidence ofsecondary deposits other than same breast or axilla
(e) reasons for no treatment
(1) patient refused
(2) patient too old
(3) intercurrent disease
(4) disease too advanced
(f) survival, from diagnosis.
Table I shows the age distribution of the 230 untreated cases compared with
two treated series, one of 783 cases from the Toronto General Hospital in Ontario
(Phillips, 1954, unpublished study) and one of 993 cases from the province of
Saskatchewan (Watson, 1951). It will be noted that approximately 60 per cent
of the untreated cases are over 60 years of age with an average age of 64 years.
This average age is high compared to the two treated groups, illustrating one of
the problems in comparing series of cases.
Data on duration ofsymptoms were given for 181 ofthe untreated cases. The
average for these 181 cases was 27-1 months with the longest being 204 months
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TABLE I.-Age Distribution of Untreated and Treated Cases
of Cancer of the Breast
Proportion in each age group
Age Untreated Ontario Saskatchewan
group (%) (%) (%)
Under30 . 0 4 1.94 19
30-39 . . 4-4 8.6 10.1
40-49 . . 12-2 22.0 26.1
50-59 . . 20.2 26'2 33.5
60-69 . . 25.4 24-4 19.2
70-79 . . 25.2 14-1 8-1
80 plus. . 12-2 3-3 1.1
Average age . 64 years 56.3 years 52 years
Table II shows the extent ofthe disease in the untreated group as determined
by clinical examination. It will be noted that the 84 cases in whom the disease
was confined to the breast and to the breast and axilla have been classified as
"operable ". These cases have received further study later in this report.
TABLE II.-Extent of Disease as Determined by Clinical Examination in Cases of
Untreated Breast Cancer
Number
Extent of disease of cases Per cent
Confined to breast (operable) . . . . . 43 . 18.7
Confined to breast and axilla (operable) . . . 41 . 17.8
Fixation to chest wall or of axillary lymph nodes . 32 . 13.9
Secondary deposits of disease . . . . . 106 . 46.1
Not specified . . . . . . . . 8 . 3.5
230
Pathological proof of malignancy was obtained on 46 cases or 20 per cent of
the untreated series. Of the remaining 184 cases, a biopsy was not taken in 176
and in 8 information on this point was not given.
Table III shows the various reasons why these patients were not treated and
it will be noted that the two main reasons were that the disease was too advanced
or the patient refused treatment.
TABLE III.-Reasons for not Treating Cases of Untreated Breast Cancer
Number
Reasons of cases Per cent
Patient refused . . . . 84 . 36 5
Patient too old . . . . 19 . 8-3
Intercurrent disease . . . 5 . 2.2
Disease too advanced . . 101 . 43.9
Other . . . . . 11 . 48
Not specified . . . . 10 . 4.3
230
Two measures of survival have been calculated for this group of untreated
patients. Thefirst oftheseisthesurvivalfromthedateofexamination ordiagnosisA. J. PHILLIPS
and the second from the date ofalleged onset ofsymptoms. These data are shown
in Table IV.
TABLE IV.-Survival Calculatedfrom Date ofDiagnosis and Date of Onset
ofSymptomsfor Untreated Breast Cancer Cases
Number
Survival from of cases
Date of diagnosis . 230
Onset ofsymptoms . 181*
Mean
survival
(months)
19-2
46.2
Survival (%)
-A
1st yr.
37 0
75-2
2nd yr.
22-5
58-2
3rd yr.
15.0
44.0
4th yr.
11.5
34.0
5th yr.
9-5
28-5
10th yr.
1 3
6-6
* Data on duration of symptoms available on 181 cases only.
The average duration of life from onset of symptoms, 46-2 months, compares
with 40.5 months quoted by Daland (1927), 39.8 months quoted by Lazarus-
Barlow (1924), 39.6 months quoted by Wyard (1925) and 38.0 months quoted
by Wade (1946).
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FIG. 1.-Comparison of survival rates from onset of symptoms in two series of untreated
breast cancer patients. Daland (1927).
---- Present series.
In Fig. 1 the annual survival ratesfrom onset ofsymptoms have been compared
with those reported by Daland (1927) and it will be noted that the two groups of
cases show approximately identical trends.
Comparison with Treated Patients
The relative value oftreatment in breast cancer has been assessed by matching
each untreated operable casewith atreated onefrom the Toronto General Hospital.
Patients were matched on age at diagnosis and on age at alleged onset ofsymptoms
and a variation of one year was permitted. Since many treated patients were of
the same age as the untreated one, the selection of the treated patient was made
by using the table of random numbers. The extent of disease in the matching
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process was controlled since operable cases in the untreated series were matched
with Stages I and II in the treated group where
STAGE I is described as the tumour localized in the breast, skin not
involved and no metastasesevidentintheaxillarylymphnodesorelsewhere.
STAGE II is described as the tumour localized in the breast, moveable,
skin not involved and axillary lymph nodes involved but no other evidence
of metastases.
In the untreated series 84 cases were classified as operable and these have been
matched with 84 treated cases on the basis of age at diagnosis. The duration of
symptoms was not given on 19 ofthe untreated operable cases hence the matching
on the basis ofage at alleged onset ofsymptoms was made on 65 cases. For those
patients matched on age at diagnosis the survival rates have been calculated
from date of diagnosis and are shown in Table V and Fig. 2. The differences
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FIG. 2.-Survival rates from date of diagnosis for treated and untreated patients matched
for age at diagnosis and extent of disease. Treated. - - - - Untreated.
TABLE V.-Comparison of Survival Ratesfrom Date of Diagnosisfor Treated and
Untreated Patients Matchedfor Age at Diagnosis and Extent ofDisease
Untreated (N = 84)
Number
surviving
53
36
28
22
19
11
8
8
6
2
Per cent
63-1
42.8
33.3
26-2
22-6
13-1
9.5
9.5
7-1
2-4
* At the 0'05 level of confidence.
Treated (N = 84)
Number
surviving
70
59
45
36
31
23
18
14
10
6
Per cent
83-3
70-2
53-6
42-8
36-9
27-4
21-4
16-7
11*9
7-1
Difference
Significant*
ili,
Not significant
,. ..9
1,. ..j
Time
(years)
1
2
3
4
5
6
7
8
9
10
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between the proportions of patients surviving at each year have been tested for
significance by the chi-square technique. It will be noted that the proportion of
treated patients surviving is significantly greater than untreated at each year to
eight years.
The survival rates for untreated and treated cases matched for age at onset
of symptoms have been calculated from the date of onset of symptoms and are
shown in Table VI. The significance ofthe differences in the proportion surviving
at each year have been tested by the chi-quare method. It will be noted that the
differences are not significant except at the two-year point.
TABLE VI.-Comparison of Survival Rates from Onset of Symptoms for Treated
and Untreated Patients MatchedforAge at Onset ofSymptoms and Extent ofDisease
Untreated (N = 65) Treated (N = 65)
Time Number Number
(years) surviving Per cent surviving Per cent Difference
1 . 54 83-1 60 92-3 . Not significant*
2 . 45 69- 2 . 57 87- 7 . Significant
3 43 66.1 . 48 73-8 . Not significant
4 . 33 50-8 . 39 60.0 . ,
5 . 29 44.6 . 30 46.1 .
6 22 33*8 23 35-4 . ,, ,,
7 . 14 21.5 . 20 30-8 . .. ..
8 . 9 13-8 . 18 27*7 . 7
9 . 8 12.3 . 14 21-5 .
10 . 6 9-2 . 12 18-5 ... ..
*At the 0 05 level of confidence.
DISCUSSION
The purpose of studying untreated cases of breast cancer is two-fold since it
provides information on the natural history of the disease as well as an oppor-
tunity to assess the efficacy of treatment. However, the number of such cases
is limited since patients who do not receive surgery or radiation therapy often
receive hormone therapy and therefore must be considered as having been treated.
Further, those who are untreated are often not followed hence the survival time
is unknown. With these limiting factors it is felt that the present series of 230
cases constitutes a substantial sample ofthis type of cancer patient.
Since the average age ofthis untreated group is considerably greater than that
of treated groups one is not justified in comparing the untreated series with a
treated one. To overcome this problem and to ensure that some measure of simi-
larity exists between the two groups it becomes necessary to consider matching
patients. In the matching process three variables have been considered, age at
diagnosis, extent of disease and duration of symptoms as determined by age at
alleged onset ofsymptoms. The validity ofdata on alleged duration ofsymptoms
has been questioned repeatedly. In the untreated cases being studied the average
duration of symptoms was 27.1 months which is considerably greater than that
reported in treated series and the lack of significance in the survival from onset
ofsymptoms between treated anduntreated patients may be dueto inconsistencies
in these data.
Another factor which affects the matching ofuntreated and treated patients is
the proportion of cases in each group having pathological proof of malignancy.
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In most treated series the proportion is approximately 75 per cent and it is
probably closer to 100 per,cent in the matched treated patients being considered
in this paper. On the other hand only 17*5 per cent of the matched untreated
cases were diagnosed pathologically. This weighting of untreated cases on the
side of clinical diagnosis as opposed to microscopic could favour the untreated
group by including lesions which woid be diagnosed microscopically as benign.
SUMMARY
A study has been made of 230 cases ofuntreated breast cancer.
The naturalhistory ofthe disease as revealed by these cases has been compared
with an earlier series by Daland (1927).
The average age and average duration of symptoms for the untreated cases
were greater than those reported for treated cases.
Untreated operable patients have been matched with treated operable patients
from the Toronto General Hospital, Ontario, on the basis of age at diagnosis and
age at onset ofsymptoms.
In comparing treated and untreated patients, matched for age at diagnosis
it was found that:
(a) the survival rate calculated from date ofdiagnosis was significantly
greater for treated patients than for untreated ones for each year to eight
years.
In comparing treated and untreated patients, matched for age at onset of symp-
toms, it was found that:-
(b) the survival rate calculated from onset ofsymptoms was consistently
higher for treated patients than for untreated ones but the differences
were not significant.
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